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Transport and biosynthesis of folate and its deriva-
tives are frequently controlled by the tetrahydrofolate
(THF) riboswitch in Firmicutes. We have solved the
crystal structure of the THF riboswitch aptamer in
complex with folinic acid, a THF analog. Uniquely,
this structure reveals two molecules of folinic acid
binding to a single structured domain. These two
sites interact with ligand in a similar fashion, primarily
through recognition of the reduced pterin moiety.
7-deazaguanine, a soluble analog of guanine, binds
the riboswitch with nearly the same affinity as its
natural effector. However, 7-deazaguanine effects
transcriptional termination to a substantially lesser
degree than folinic acid, suggesting that the cellular
guanine pool does not act upon the THF riboswitch.
Under physiological conditions the ligands display
strong cooperative binding, with one of the two sites
playing a greater role in eliciting the regulatory
response, which suggests that the second site may
play another functional role.
INTRODUCTION
Folic acid is an essential micronutrient that plays a central role in
one-carbon metabolism. In its reduced form, tetrahydrofolate
(THF) (Figure 1A, [1]), it is a carrier of one-carbon units in the
form of methyl, methylene, or formyl groups that are utilized in
methionine, thymidine, and purine biosynthesis, respectively
(Bermingham and Derrick, 2002). Its deficiency is directly linked
to a broad range of human health issues including birth defects,
cardiovascular disease, and increased cancer risk (Suh et al.,
2001). As an important nutrient, efforts are being devoted to
improving biofortification of folate in bacteria and plants to
combat a significant health problem in developing countries
(Bekaert et al., 2008; Sybesma et al., 2004; Zhu et al., 2005).
Folate biosynthesis is also a significant target for antimicro-
bial therapeutics (Bermingham and Derrick, 2002). For example,
one of the most long-standing and successful classes of drugs,
the sulfonamides, targets the attachment of the para-amino-
benzoate (pABA) moiety to 7,8-dihydropterin. As these and
other folate biosynthetic reactions are absent in animals, itStructure 19, 1413–1makes this pathway a proven approach for the design of new
antibacterial agents (Suh et al., 2001). For both bioengineering
and drug discovery applications, exploiting the regulation of
bacterial folic acid synthesis and transport is a potentially
important avenue.
In bacteria, particularly the Firmicutes and Fusobacteria, many
central metabolic pathways are regulated at the RNA level. One
of the most pervasive forms of regulation by RNA is the ribos-
witch, an element located in the 50 leader sequence that directly
binds a metabolite, which determines the state of a downstream
secondary structural switch (Roth and Breaker, 2009). These
regulatory elements direct expression at either the translational
or transcriptional level. For example, small-molecule binding to
a transcriptional repressor element fates the mRNA to form
a classic rho-independent transcriptional terminator that causes
RNA polymerase to abort synthesis (Roth and Breaker, 2009).
Knowledge of this regulation has enabled engineering of bacteria
for enhanced production of inosine and thiamine by altering the
regulation by riboswitches associated with the regulation of the
biosynthesis of these compounds (Asahara et al., 2010; Tokui
et al., 2011).
Recently, a new class of riboswitches that bind THF was
discovered (Ames et al., 2010). Found primarily in Firmicutes,
the THF riboswitch is found associated with mRNAs encoding
genes that regulate folate transport (folT) or biosynthetic (folC
and folE) genes. The THF receptor (aptamer domain) of this
riboswitch comprises an 100 nucleotide element predicted to
form four helices and contain a three-way junction and a pseudo-
knot (Figure 1B) (Ames et al., 2010). Nucleotides conserved in
>97% of identified sequences are distributed around the three-
way junction and pseudoknot. This RNA specifically binds
reduced forms of folate, including THF and dihydrofolate
(DHF), as well as 5- and 10-modified forms of THF whereas
rejecting folic acid (Figure 1A, [2]). Because the biologically
active form of folate is THF and its derivatives, this suggests
that the riboswitch is only monitoring the active fraction of the
total intracellular folate pool and turning off folate transport
and/or biosynthesis in response. Furthermore, the RNA is able
to bind tetrahydrobiopterin with approximately the same affinity
as THF, suggesting that the riboswitch does not significantly
interact with the p-aminobenzoate or glutamyl moieties (Ames
et al., 2010).
To reveal the molecular basis for recognition of THF and regu-
lation by this riboswitch, we determined its three-dimensional
structure in the presence of the THF analog folinic acid (Fig-
ure 1A, [3]). The RNA folds into a commonplace architecture423, October 12, 2011 ª2011 Elsevier Ltd All rights reserved 1413
Figure 1. Structures of Ligands and RNA Used in
This Study
(A) Chemical structures of tetrahydrofolate (1), folate (2),
folinic acid (3), and 7-deazaguanine (4). The R group of
compounds (2) and (3) corresponds to the para-amino-
benzoate/glutamyl moieties in THF.
(B) Secondary structure of the aptamer domain of the
S. mutans folT riboswitch. The regions shaded in gray
were changed from the wild-type sequence to facilitate
transcription and crystallizability.
Structure
Structure of the THF Riboswitchinvolving side-by-side placement of two sets of coaxially
stacked helices organized by a three-way junction and distal
pseudoknot interaction. The reduced pterin moiety of folinic
acid mediates most of its interaction with the RNA. Surprisingly,
two molecules of folinic acid are observed in the structure, with
specific binding sites located in the junction and the pseudo-
knot. At physiological magnesium concentrations, we observe
strongly cooperative binding of the two ligands. However, only
one of these sites is necessary to elicit a strong regulatory
response, suggesting that the second site may fulfill another
role in regulation such as promoting efficient cotranscriptional
folding of the RNA.
RESULTS
Structure of the THF Riboswitch
To obtain crystals of the aptamer domain of the THF riboswitch,
five sequences were surveyed for initial crystallization. One of
the sequences, a THF riboswitch that controls the folT gene in
Streptococcus mutans (Smu) UA159 (Ames et al., 2010), yielded
crystals in a sparse matrix and was subsequently modified to
improve crystal quality. Two sets of changes were made to this
sequence: two base pairs of the first helix (P1) were changed
to G-C to promote transcription, and P4 was changed to a
tetraloop to facilitate crystallization (Figure 1B, gray boxes).
This sequence, which binds with slightly lower affinity than the
wild-type aptamer (KD,app = 18 ± 1 mM versus 7.9 ± 0.1 mM,
respectively), reproducibly yielded diffraction-quality crystals.
Further improvements in crystal quality were made by using
the THF derivative folinic acid (FA; Figure 1A, [3]), which contains1414 Structure 19, 1413–1423, October 12, 2011 ª2011 Elsevier Ltd All rights reservea formyl modification at the 5 position. This
compound binds the riboswitch with the same
affinity as THF (KD,app = 23 ± 7 mM), consistent
with the observation that the RNA does not
discriminate between various one-carbon
carrier forms of THF (Ames et al., 2010). Cocrys-
tallization in the presence of 1 mM iridium hex-
ammine (Keel et al., 2007) yielded a derivative
used to calculate an experimental electron
density map containing very clear RNA features.
The final model, refined against data extending
to 2.27 A˚, has good statistics and geometry
(Table 1).
The overall architecture of the THF riboswitch
consists of two sets of coaxially stacked helices
positioned in a side-by-side arrangement via
formation of a pseudoknot (Figure 2). The firstset of coaxially stacked helices comprises helices P1, J2/1-L3,
and P3, whereas the second is formed by P2 and P4. The place-
ment of these coaxial stacks is enforced by a three-way junction
(3WJ) motif between P2, P3, and P4 and a pseudoknot between
L3 and J2/1. The overall topology of the 3WJ is similar to the
global architecture of the thiamine pyrophosphate and cyclic-
di-GMP riboswitches (Kulshina et al., 2009; Serganov et al.,
2006; Smith et al., 2009; Thore et al., 2006), all of which belong
to the ‘‘family B’’ 3WJ category according to a categorization
by Westhof (Lescoute and Westhof, 2006). Like many three-
way junction motifs, the organization of the helices is enforced
by a distal tertiary interaction (de la Pen˜a et al., 2009). In the
THF riboswitch, it is a pseudoknot formed through a series of
five Watson-Crick pairs between L3 and J2/1 (P-PK; Figure 2A).
The architecture of this pseudoknot is that of an HL-type (helix-
loop) pseudoknot in which the principal two helices, P1 and
P-PK, are coaxially stacked (Han and Byun, 2003).
Unlike any other RNA aptamer characterized to date, natural
or in vitro selected, our structure revealed that the THF ribos-
witch contains two ligand binding sites presented within a single
structured domain. This is in contrast to the dual aptamer
domains found in the glycine riboswitch in which each of two
structured domains binds a single ligand (Mandal et al., 2004).
The first binding site (FAPK) is adjacent to the pseudoknot on
the minor-groove face of the site of coaxial stacking between
P-PK and P3 (Figure 2B). Recognition of the reduced pterin
moiety is mediated by three uridine residues: U35 and U42 in
L3, and U7 in J1/2. The N2/N3 edge of the pterin (numbering
shown in Figure 1A) forms hydrogen bonds with the two uridines
in L3 (Figure 3A). The N1/N8 of the pterin interacts with thed
Table 1. Crystallographic Statistics
Crystal Smu Wild-Type Smu (U25C)
Data Collection
Space group P 21 21 21 P 21 21 21
Cell dimensions
a, b, c (A˚) 27.6, 68.2, 157.6 27.5, 68.6, 158.1
a, b, g () 90, 90, 90 90, 90, 90
Resolution (A˚) 52.5–2.27
(2.33–2.27)
62.9–1.95
(2.01–1.95)
Rp.i.m. 0.038 (0.493) 0.025 (0.431)
Mn (I/sI) 14.3 (2.0) 20.3 (2.5)
Completeness (%) 96.4 (98.9) 98.4 (97.1)
Redundancy 4.1 (3.6) 3.5 (3.7)
Wavelength (A˚) 1.1051 1.1051
Phasing
Number of heavy atoms 5 5
Figure of merit (before DM) 0.34 0.36
Refinement
Resolution (A˚) 28.6–2.27 62.9–1.96
Number of reflections 23,076 22,038
Rwork/Rfree 23.4/27.2 22.8/24.4
Number of atoms
RNA 1,913 1,913
Ion 49 35
Ligand 50 22
Water 40 103
B factors
RNA 33.6 39.5
Ion 40.8 93.4
Ligand 31.9 41.0
Water 29.0 35.4
Rmsd
Bond lengths (A˚) 0.002 0.002
Bond angles () 0.513 0.502
PDB ID code 3SD1 3SD3
DM, density modification.
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Structure of the THF RiboswitchWatson-Crick face of U7. Whereas the first ring stacks with A8,
the second ring, which is in the reduced form and thus not planar,
displays little stacking with the RNA. The pABA moiety interacts
with the RNA through stacking of the benzene ring with back-
bone atoms in A80 of J2/1. No clear electron density in the final
2Fo  Fc map or an omit map (see Figure S1 available online)
could be associated with the glutamate moiety. It is likely that
it does not interact with the RNA and is thus disordered, consis-
tent with previous observations (Ames et al., 2010). This likely
reflects the fact that folate is polyglutamylated in many bacteria
to promote intracelluar retention (Shane, 1989). Tetrahydrobiop-
terin, which lacks both the pABA and glutamyl moieties, binds
with only4-fold lower affinity than THF (Ames et al., 2010), indi-
cating that the majority of binding energy is obtained through
interactions mediated by the pterin moiety.
The second ligand (FA3WJ) is bound to a site in the minor
groove in the P3 adjacent to the three-way junction in a fashionStructure 19, 1413–1similar to the FAPK site (Figure 3B). The N2/N3 edge of the pterin
moiety of FA3WJ forms a reverse Watson-Crick-type pair with
C53, whereas the N1/N8 edge forms three hydrogen-bonding
interactions with U25. Like the FAPK site, the first ring of the pterin
moiety shows stacking interactions with adjacent nucleobases
(G26 and G54), but the second ring does not significantly stack
with the RNA. The pABA moiety interacts with this site through
stacking interactions with a bulged guanosine (G68). Also,
similar to FAPK, no electron density supporting specific posi-
tioning of the glutamate moiety in the second site was observed.
There are two likely reasons for this RNA’s ability to discrimi-
nate between reduced forms of folate (THF and DHF) and the
fully oxidized form in both sites. First is the formation of
a hydrogen-bonding interaction between N8 of the ligand and
U7 or U25. This can only occur in the reduced forms of folate,
DHF and THF, which carry a hydrogen at this position (Figure 1A).
Another possible means of discrimination is the different posi-
tioning of the pABA/glutamylmoiety in folate and THF. Reduction
of the second ring of the pterin moiety breaks the planarity of the
ring, resulting in a repositioning of the pABA/glutamyl moieties.
Superimposition of folate onto folinic acid via their pterin rings
in each of the two sites revealed no potential steric clashes
between folate and the RNA in either site (data not shown).
However, in folate, the pABA moiety can no longer stack upon
A80 in the pseudoknot site or G68 in the junction site.
Binding of Guanine to the THF Riboswitch
In consideration that the RNA primarily interacts with the pterin
moiety of folinic acid, this riboswitch might be able to interact
with planar compounds with a similar constellation of hydro-
gen-bond donors and acceptors. The most obvious candidate
is guanine, which can easily be modeled into both THF sites
and satisfies all of the hydrogen-bonding and stacking interac-
tions as the reduced pterin moiety. The limited solubility of
guanine—100 mM at saturation—became a technical problem
for some of the experiments used in this study. However, in
both sites, the N7 of guanine would likely not interact with the
RNA, and thus the soluble analog 7-deazaguanine (7DG) (Fig-
ure 1A, [4]) was considered a reasonable proxy. To confirm
that 7-deazaguanine is a suitable analog for guanine, we
measured their affinity for the wild-type THF aptamer and
observed that they were nearly identical.
To determine whether THF and guanine bind to the Smu THF
riboswitch in similar fashions, we probed its solution structure
with N-methylisatoic acid (NMIA), a chemical reagent that
selectively reacts with conformationally dynamic regions of
RNA (Wilkinson et al., 2006). Probing the RNA in the presence
of folinic acid and 7-deazaguanine demonstrated that the latter
is capable of inducing a nearly identical pattern of reactivity
changes as folinic acid (Figure 4A). Importantly, we observed a
protection pattern that is consistent with 7-deazaguanine occu-
pying both sites. The only significant difference is G68, which
stacks with the pABA moiety in the crystal structure. Whereas
folinic acid protects this nucleotide from NMIA modification, in
the presence of 7-deazaguanine, which lacks an analogous
chemical moiety, G68 remains reactive.
This result was further validated using isothermal titration
calorimetry (ITC) (Table 2). Under high-magnesium conditions,
7-deazaguanine displays nearly equal binding affinity as folinic423, October 12, 2011 ª2011 Elsevier Ltd All rights reserved 1415
Figure 2. Global Structure of the Aptamer Domain of the THF Riboswitch
(A) Secondary structure of the RNA used in the structure determination, redrawn to reflect the tertiary structure and include noncanonical base pairs, denoted
using Leontis-Westhof notation (Leontis and Westhof, 2001). The two molecules of folinic acid (FAPK and FA3WJ) observed in the crystal structure are denoted
in red.
(B) Cartoon representation of the global architecture of the THF aptamer. Coloring of the RNA is consistent with (A).
(C) Ninety degree rotation of the perspective shown in (B); note the placement of both THF binding sites on the same face of the RNA.
See also Figure S1.
Structure
Structure of the THF Riboswitchacid. Both compounds also display similar enthalpic and en-
tropic contributions to binding, further reinforcing that THF and
guanine can interact with this riboswitch in nearly identical
fashions. At a more physiological magnesium concentration
(0.5 mM for the purposes of this study), the affinity of the RNA
for 7-deazaguanine drops by 2 fold relative to folinic acid.
To determine whether guanine is also capable of acting as an
effector of the THF riboswitch, we employed an in vitro transcrip-
tion assay that has been previously used to study riboswitch
function (Artsimovitch and Henkin, 2009; Dann et al., 2007).
The Smu THF riboswitch, unfortunately, does not contain an
easily recognizable expression platform that would indicate
whether it regulates at the transcriptional or translational level.
Thus, we tested a riboswitch found in the human gut metage-
nome (BABG01026644.1/586-688) (Ames et al., 2010) that
clearly contains a stem-loop structure that could act as a classic
rho-independent transcriptional terminator. Unfortunately, we
did not observe any folinic acid-dependent switching of this
RNA under various conditions that yields robust regulatory
responses with other riboswitches in single-turnover transcrip-
tion assays.
In the course of our studies of various riboswitches, we have
observed that activities of the aptamer and expression platform
are separable to the extent that they can be ‘‘mixed and
matched’’ (Stoddard and Batey, 2006). For example, we can
create a chimera in which aptamer domains from various ribos-1416 Structure 19, 1413–1423, October 12, 2011 ª2011 Elsevier Ltdwitches can be spliced into the expression platform of the
Bacillus subtilis metE SAM-I riboswitch to yield synthetic ribos-
witches regulated by the effector of the transplanted aptamer
(P.C., A.D. Garst, J. Marcano, and R.T.B., personal communica-
tion). The T50 (the concentration of ligand that elicits a half-
maximal regulatory response) of these chimeras is principally
dictated by the aptamer domain; the yitJ SAM-I riboswitch
aptamer regulates at nearly identical S-adenosylmethionine
(SAM) concentrations in the context of the B. subtilis metE and
lysC expression platforms as the wild-type riboswitch (P.C.,
A.D. Garst, J. Marcano, and R.T.B., personal communication).
This chimeric approach has previously been employed to dissect
functional domains of bacterial small noncoding RNAs (Papen-
fort et al., 2010). We therefore designed a chimeric riboswitch
that would allow us to study THF-dependent regulation (Figures
S2 and S3). Nucleotides 5–84 (Figure 1B) of the aptamer domain
of the wild-type Smu THF riboswitch were attached to the
expression platform of the B. subtilis metE expression platform
such that the secondary structural switch in the expression
platform was not altered.
Regulation of the Smu folT/Bsu metE chimeric riboswitch
showed strong folinic acid-dependent transcriptional termina-
tion (Figure 4B). Importantly, this chimera shows no response
to SAM (Figure S4), indicating that the Smu aptamer controls
the effector specificity of the riboswitch. Fitting the data to the
Hill binding equation yields a T50 = 44 ± 3 mM, consistent withAll rights reserved
Figure 3. Recognition of Folinic Acid by the THF Riboswitch
(A) Interactions between the RNA and the ligand in site PK. Hydrogen-bonding
interactions are denoted by gray dashes. For each nucleotide in direct contact
with folinic acid, the degree of conservation observed across 57 sequences
(Ames et al., 2010) is given as a percent identity of each nucleotide type.
(B) Interactions between RNA and ligand in site 3WJ.
(C) Recognition of guanine by the guanine riboswitch (from PDB ID code 1Y27;
Serganov et al., 2004).
(D) Recognition of preQ1 by the preQ1 riboswitch (from PDB ID code 2KFC;
Klein et al., 2009).
See also Figures S1 and S5 and Table S1.
Figure 4. Binding of a Guanine Derivative to the THF Riboswitch
(A) NMIA chemical probing of the THF riboswitch at two different magnesium
conditions in the presence of either folinic acid (FA) or 7-deazaguanine (7DG).
Note the nearly identical protection patterns induced by the two ligands at both
the pseudoknot site (L3, FAPK) and the three-way junction (J2/3, FA3WJ).
(B) Fitting of representative data from transcription assay titration of folinic acid
and 7-deazaguanine to the chimeric switch to the Hill equation. Each data
point represents the average of three independent experiments, with the error
bars indicating the standard deviation.
See also Figures S2–S4.
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Structure of the THF Riboswitchthe previous binding data. Titration of this chimera with 7-deaza-
guanine yielded an observed T50 > 3500 mM (Figure 4B). A partial
titration of the riboswitch with guanine up to 60 mM showed no
termination, consistent with 7-deazaguanine. Although the tran-
scription conditions do not exactly match the expected in vivo
magnesium or NTP concentrations and use Escherichia coli
RNA polymerase, these data indicate that guanine is a substan-
tially less effective regulator of theS.mutans riboswitch than THF
despite it binding with nearly identical affinity.
Cooperative Ligand Binding to the THF Riboswitch
An unusual aspect of this structure is the presence of two bound
ligands. A formal possibility is that one of these sites is fortu-
itously occupied by THF and does not represent a biologically
relevant site. Examination of the published phylogeny of the
THF riboswitches reveals that each of the nucleotides that
directly contacts the pterin moiety of each ligand is among the
most highly conserved in the RNA (Figures 2A and 2B). These
data suggest that in fact both ligand binding sites are conserved
in the THF family, and are not an artifact of crystallization at high
THF concentrations or an unusual sequence.
To explore the relationship between the two sites, we made
a set of point mutations that ablate each site. These mutants
disrupt folinic acid binding by changing the uridine that interacts
with the N1/N8 edge of pterin with cytosine: U7C (FAPK site),
U25C (FA3WJ site), and U7C/U25C (both sites). Based upon the
structure, each mutation would reduce the potential number ofStructure 19, 1413–1hydrogen bonds with the ligand by two, severely destabilizing
the interaction. Each of these mutants was probed using NMIA
to verify that the secondary and tertiary structure of the RNA
was not altered and that the unmodified site retains folinic acid
binding activity (data not shown). As a further validation, we ob-
tained a crystal structure of the U25C mutant bound to a single
folinic acid (Table 1), and observed a nearly identical global
structure with the wild-type complex (least-squares root-
mean-square deviation [rmsd] = 0.71 A˚). The only significant
difference is that the G24,G54 pair immediately above the
3WJ site rearranges such that the Watson-Crick face of G54
hydrogen bonds with a nonbridging phosphate oxygen of A23
(Figure S5). Whereas site PK was occupied by a well-ordered
ligand, site 3WJ does not contain a ligand, as no electron density
was observed adjacent to C25 in a 2Fo Fcmap (Figure S5). This
demonstrates that this mutant completely abrogates binding at
site 3WJ. Notably, crystals of the U7Cmutant were not obtained,
suggesting that folinic acid binding to this site may be critical for
proper structure formation under the crystallization conditions.
The affinity and stoichiometry of each RNA for THF was deter-
mined using ITC (Table 2). At high-magnesium concentration423, October 12, 2011 ª2011 Elsevier Ltd All rights reserved 1417
Table 2. Thermodynamic Parameters for Ligand Binding to the THF Riboswitch at 25C
RNA Ligand MgCl2 (mM) KD (mM) DH (kcal/mol) TDS (kcal/mol) n
a
WT Folinic acid 6 18 ± 1 15 ± 1 8.0 ± 0.2 2.1 ± 0.1
WT Folinic acid 0.5 22 ± 2 15 ± 1 9.1 ± 0.1 2.0 ± 0.1
WT 7-deazaG 6 24 ± 1 20 ± 1 14 ± 1 2.0 ± 0.1
WT 7-deazaG 2.5 26 ± 2 19 ± 1 13 ± 1 2.0 ± 0.1
WT 7-deazaG 0.5 38 ± 1 30 ± 1 24 ± 1 2.1 ± 0.1
U7C Folinic acid 6 23 ± 2 20 ± 1 13 ± 1 1.1 ± 0.1
U25C Folinic acid 6 18 ± 1 11 ± 1 4.1 ± 0.2 1.3 ± 0.1
U7C/U25C Folinic acid 6 nd nd nd nd
U7C Folinic acid 0.5 140 ± 7 30 ± 1 25 ± 1 1.1 ± 0.1
U25C Folinic acid 0.5 340 ± 10 19 ± 1 14 ± 1 1.2 ± 0.1
U7C/U25C Folinic acid 0.5 nd nd nd nd
nd, no detectable binding.
a n is a fitted parameter that reflects the number of ligand binding sites.
Structure
Structure of the THF Riboswitch(6 mM), the wild-type aptamer shows an apparent affinity (KD)
of 20 mM for THF and a stoichiometry of 2:1 THF:RNA.
Although the apparent affinity is lower than that observed for
the Alkaliphilus metalliredigens folT riboswitch (70 nM) (Ames
et al., 2010), it is not outside the range of observed dissociation
constants for riboswitch-ligand interactions (Ames and Breaker,
2011; Sudarsan et al., 2003). Each of the two single-point
mutants displayed similar affinities at 6 mM MgCl2, but each
binds a single ligand (Table 2), indicating that these mutations
ablate THF binding at the corresponding site. These data further
reveal that each site binds ligand independently—there is no
cooperative binding. To further validate this finding, we
measured the binding of folinic acid for the Smu THF aptamer
using NMIA chemical probing at 6 mM magnesium (Figure 5A).
Fitting the folinic acid-dependent protections at each binding
site to a multisite binding model yielded a Hill coefficient of 1,
clearly indicating independent binding (Figure 5B).
At a lower, more physiological magnesium concentration
(0.5 mM), the affinity of the wild-type RNA for folinic acid remains
essentially unchanged (Table 2). However, for both single-site
mutants, the apparent affinity for folinic acid dropped by 5- to
10-fold. The lowered values for each individual site indicate
that abolishing ligand binding to one site is deleterious to binding
to the other site under physiological magnesium concentrations.
One explanation for this result is that at physiological concentra-
tions of monovalent and divalent cations, binding to the two sites
is cooperative. However, these data indicate that the single-
point mutants are not entirely nonperturbing to the other site,
preventing our quantifying the energetic contribution of cooper-
ativity to ligand binding. Instead, we performed NMIA footprint-
ing of the wild-type RNA at 0.5 mM magnesium chloride and
quantified folinic acid-dependent protections in both sites using
a Hill equation (Weiss, 1997). This analysis yielded a fitted Hill
coefficient (nH) of 1.8 (Figure 5B), indicative of strong cooperative
binding between the two sites. Together with the above data, this
suggests that at low magnesium the local binding sites are not
fully structured, despite a nearly identical NMIA reactivity pattern
at 6 mM Mg2+.
Regulation by riboswitches is often obligatorily cotranscrip-
tional such that it is a ‘‘kinetic controlled’’ process in which the1418 Structure 19, 1413–1423, October 12, 2011 ª2011 Elsevier Ltdligand concentration required to elicit a response is inconsistent
with affinity measurements of the isolated aptamer (Wickiser
et al., 2005a, 2005b). Thus, we measured the ability of each of
the mutants to regulate transcription in the context of the
Smu folT/Bsu metE chimeric switch (Figure 6A). The U25C
mutant that knocks out the three-way junction showed an
3-fold drop in its T50 compared to the wild-type chimera, indi-
cating that site PK is capable of regulation without a functional
3WJ site. This RNA shows no cooperativity in its ligand response
curve, unlike thewild-type RNA that showsweak apparent coop-
erativity (nH = 1.2 ± 0.1) (Figure 6B). This value is consistent with
a moderate Hill coefficient of binding (nH = 1.4 ± 0.2) measured
at a magnesium concentration equivalent to that in the transcrip-
tion assay (2.5 mM). Conversely, the U7C mutant showed very
low regulatory activity (Figure 6B, yellow curve), suggesting
that site PK is most important to THF riboswitch function. The
strong disparity between the two sites’ abilities to regulate
expression despite their similar affinities for ligand may indicate
that they have separate roles in the function of the riboswitch.
DISCUSSION
The THF riboswitch is unique among known riboswitches and
aptamers in that it contains two ligand binding sites within a
single structured domain. Whereas each site is in the context
of a different structural motif, a multihelix junction and a pseudo-
knot, the modes of THF recognition are strikingly similar. This is
reflected by the similar affinities of each site for folinic acid and
7-deazaguanine. In contrast, single-round transcriptional assays
reveal that the pseudoknot site is substantially more important
for eliciting a regulatory response. These data may suggest
that the ancestral THF riboswitch could have functioned with a
single site in the pseudoknot, with the second site evolving sub-
sequently. Of the 57 sequences identified as candidate THF
riboswitches by Ames et al. (2010), it is notable that there is
slightly less conservation in site 3WJ than in site PK (Figure 3;
Table S1), suggesting that single-site THF riboswitches may
still be biologically relevant. Most of these potential single-site
variants have multiple changes in the altered site, indicating
that they contain only a single functional binding site for THF.All rights reserved
Figure 5. Cooperative Binding of Folinic Acid to the THF Riboswitch
(A) Bands corresponding to nucleotides 36–43 in an NMIA-probing experiment
in which the RNA was bound by various concentrations of FA ranging from
0.1 to 500 mM at two different magnesium conditions.
(B) Plot of data averaged from three individual titrations fit to a Hill equation.
The two curves represent the fit to data taken in 6 mM (solid) and 0.5 mM
magnesium (dashed). Each data point represents the average of three inde-
pendent experiments, with the error bars indicating the standard deviation.
Figure 6. Single-Turnover Transcription Assays of THF Riboswitch
Mutants
(A) Transcription assays of the wild-type, U7C (PK mutant), U25C (3WJ
mutant), and double mutants. Each riboswitch was transcribed in the absence
of ligand (- lanes), 200 mM folinic acid (FA lanes), or 7-deazaguanine (7DG
lanes). RT denotes the readthrough transcription product, and T denotes the
terminated product. The percent of transcript terminated is given below each
lane. These values represent the average of at least three independent repli-
cations of the assay.
(B) Data from titration of the wild-type, U7C, and U25C THF riboswitches with
folinic acid and fitting each data set to a Hill equation. Each data point
represents the average of three independent experiments, with the error bars
indicating the standard deviation.
See also Figures S2 and S3.
Structure
Structure of the THF RiboswitchInterestingly, the recognition of the pterin moiety by the THF
riboswitch is in many ways analogous to nucleobase recognition
by other natural and in vitro selected RNA aptamers. For
example, the purine riboswitch forms a base triple with guanine
similar to the base triples observed in both THF sites (Figure 3C)
(Batey et al., 2004; Noeske et al., 2005; Serganov et al., 2004).
Within the purine riboswitch family, the pyrimidine that hydrogen
bonds to the Watson-Crick face of the nucleobase dictates the
specificity for guanine versus adenine, whereas the pyrimidine
that interacts with the N3/N9 face (equivalent to the N1/N8
edge of the pterin ring) determines the specificity for guanine
versus deoxyguanosine (Edwards and Batey, 2009). A similar
mode of recognition is used by the preQ1 riboswitch to recognize
guanine derivatives (Figure 3D), where hydrogen-bonding inter-
actions between theWatson-Crick andN3/N9 faces of the ligand
are the primary means of interaction (Kang et al., 2009; Klein
et al., 2009; Spitale et al., 2009). Recognition of theophylline
(1,3-dimethylxanthine) by an in vitro selected aptamer is also
achieved using two pyrimidines that form a base triple with
the ligand (Zimmermann et al., 1997). These examples of conver-
gence upon a similar solution for binding nucleobases suggest
that it may be possible to evolve simple binding sites in
numerous structural contexts.
A consequence of recognition of primarily the pterin moiety
of THF is that the riboswitch also binds guanine, suggesting
the possibility that it is regulated by both metabolites. InStructure 19, 1413–1glucose-fed rapidly growing E. coli, the intracellular concentra-
tion of guanine has been measured to be 200 mM (Bennett
et al., 2009). Whereas a similar measurement for THF in E. coli
has not been performed, the KM for serine hydroxymethyltrans-
ferase, an enzyme that transfers a one-carbon unit from serine
to THF, is 25 mM (Schirch et al., 1985), which serves as a
good estimate for the minimal intracellular concentration of
THF (Bennett et al., 2009). Additionally, estimates of the folate
pools in B. subtilis and Lactococcus are in the 10–50 mM range
(Sybesma et al., 2003; Zhu et al., 2005). Given these estimates
and the observation that the T50 of folinic acid is100-fold lower
than 7-deazaguanine, it is likely that the S. mutans riboswitch is
almost entirely responsive to the total reduced folate pool in the
cell rather than guanine. However, another THF riboswitch from
A. metalliredigens binds THF with 100-fold greater affinity
(70 nM) (Ames et al., 2010), which may translate into a much
lower T50 for THF and guanine such that both could regulate
under physiological conditions. Given that GTP is the starting
substrate in the synthesis of THF, as well as THF being involved
in two separate steps of GTP biosynthesis, it may not be
surprising that a riboswitch may need to sense both reduced
folate and guanine pools in vivo. This idea is reinforced by the
observation that the PurR repressor, which uses hypoxanthine423, October 12, 2011 ª2011 Elsevier Ltd All rights reserved 1419
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Structure of the THF Riboswitchand guanine as corepressors, regulates the expression of the
serine hydroxyltransferase (glyA) in E. coli (Steiert et al., 1992).
The inability of 7-deazaguanine to effect transcriptional termi-
nation by the S. mutans THF aptamer despite a similar equilib-
rium dissociation constant (KD) to folinic acid underscores a
kinetic relationship between ligand binding and regulation. In
regulation at the transcriptional level, readout of the secondary
structural switch by RNA polymerase occurs within seconds of
the aptamer domain acquiring the ability to interrogate the
cellular environment (Wickiser et al., 2005b). The rate at which
the aptamer reaches equilibrium is governed by the relaxation
equation t1 = kon[ligand] + koff where t, the time constant, is
the time required for 1-e1 (63.2%) of the population to reach
the final steady-state equilibrium. If genetic readout occurs prior
to the aptamer fully reaching equilibrium, then the kinetic rates
determine the concentration of ligand required to achieve a re-
gulatory response, resulting in regulation at ligand concentra-
tions in excess of that expected by the measured KD. Although
we have not measured association and dissociation rates for
folinic acid and 7-deazaguanine, the latter may have a signifi-
cantly longer time constant. This results in substantially higher
concentrations to effect transcriptional termination by 7-deaza-
guanine as compared to folinic acid (Figure 4B). This observation
is relevant to the design of antimicrobials that target riboswitches
(Blount and Breaker, 2006); compounds that bind with an affinity
comparable to the natural ligand may not be capable of genetic
regulation.
There are several reasons why this riboswitch might have
evolved multiple sites to facilitate regulation. The first is that it
senses the total THF/guanine intracellular pool. In vitro transcrip-
tion data demonstrate that by itself guanine is a poor effector of
regulation, but that may be the result of poor binding to the FAPK
site. Instead, guanine might act primarily at the FA3WJ site to
assist in folding of the aptamer (see below). A second, and
more likely, explanation for two ligand binding sites is to enable
a more digital response to THF via cooperative binding. Under
physiological magnesium conditions, we observe strong coop-
erative binding (nH = 1.8) between the two ligands using NMIA
chemical probing (Figure 4). This is a similar value for the Hill
coefficient measured for the glycine riboswitch, an RNA that
uses two tandem aptamers and achieves cooperative binding
through ligand-dependent formation of interdomain interactions
(Butler et al., 2011; Mandal et al., 2004). Unfortunately, we were
not able to perform transcription assays under these conditions;
the lowest concentration of magnesium at which reliable data
could be acquired was 2.5mM.Under this condition, we observe
only moderate (nH = 1.4; Figure 5B) cooperative binding between
the sites aswell as in the transcription assay (nH = 1.2; Figure 6B).
Nonetheless, the close agreement of these values indicates that
transcriptional regulation under physiological conditions could
be facilitated through cooperative binding of ligand at the two
sites.
Cooperative binding of the ligands may also be required to
promote rapid and efficient folding of the aptamer. Many ribos-
witches act cotranscriptionally and therefore have a short
temporal window in which to act prior to the escape of RNA poly-
merase into the coding region. Thus, the RNA must be able to
efficiently and rapidly fold and interrogate the cellular environ-
ment for the presence of the effector in order to control gene1420 Structure 19, 1413–1423, October 12, 2011 ª2011 Elsevier Ltdexpression. During transcription, the three-way junction would
be synthesized first and start to fold. An RNA spanning nucleo-
tides 19–90 of the A. metalliredigens RNA (equivalent to 9–78
of the Smu riboswitch) is capable of binding ligand, albeit at
a reduced affinity (Ames et al., 2010). Thus, binding of ligand to
site 3WJ could facilitate organization of the three-way junction
to place L3 in proximity to J2/1 to form the pseudoknot and
site PK. In this model, site 3WJ is not essential for regulatory
activity, as shown by the transcription assays, but rather for rapid
folding of the RNA and formation of the regulatory site in the
pseudoknot. In most other riboswitches, folding of the RNA
occurs using motifs that do not require an additional ligand.
For example, studies of the B. subtilis xpt guanine and pbuE
adenine riboswitches have demonstrated that a distal loop-
loop interaction facilitates the folding of a three-way junction
element that hosts the ligand binding site (Greenleaf et al.,
2008; Lemay et al., 2006; Stoddard et al., 2008). It is therefore
possible that the THF riboswitch initially evolved the site in the
pseudoknot as a means of establishing a regulatory site and
subsequently a second site to facilitate rapid and efficient folding
of the RNA via the three-way junction. This is consistent with our
measurement of binding at physiological magnesium concentra-
tions, where it is likely that binding of THF within the three-way
junction facilitates formation of the pseudoknot site to achieve
cooperativity.
EXPERIMENTAL PROCEDURES
RNA Transcription and Purification
A DNA template for transcription was created using PCR amplification of
overlapping oligonucleotides. The template was transcribed in vitro using T7
RNA polymerase and purified using previously described methods (Reyes
et al., 2009). Briefly, transcribed products were purified using a denaturing
polyacrylamide gel (8 M urea, 12% 29:1 acrylamide:bisacrylamide). Gel frag-
ments containing RNA were soaked in 0.53 T.E. (10 mM Tris [pH 8.0], 1 mM
EDTA) buffer to elute. Buffer exchange and concentration were performed
using Amicon Ultra 10,000 molecular-weight cutoff centrifugal concentrators.
The final concentration was calculated from the absorbance at 260 nm, and
the molar extinction coefficient was calculated from the summation of the
contributions from the individual bases.
RNA Crystallization, Structure Solution, and Refinement
RNA was crystallized by the hanging-drop/vapor-diffusion method. One
microliter of RNA ligand mix (500 mM RNA, 1 mM folinic acid) was added to
2 ml of 6% 2,4-methylpentanediol, 10 mM spermine, 40 mM Na-cacodylate
(pH 7.0), 80 mM NaCl, and 1 mM DTT and was incubated over 500 ml of
35% 2-methyl-2,4-pentanediol (MPD). Drops were allowed to equilibrate at
30C for 2–4 days, during which time rod-like crystals formed. To prepare
a suitable derivative, 1 mM iridium hexammine was added to the drop solution
prior to cryoprotection. To cryoprotect, 10% MPD was added to the crystalli-
zation solution and allowed to equilibrate for 5–10 min, and the crystals were
frozen in liquid nitrogen.
Complete data sets of a wild-type RNA and a U7C mutant were collected
at the Advanced Light Source (5.0.2). The data were indexed, integrated,
and scaled with xia2 (Winter, 2010). Significant anomalous signal throughout
the entire resolution range allowed for location of iridium heavy-atom sites,
calculation of single-wavelength anomalous dispersion phases, and density
modification via PHENIX (Adams et al., 2002). The experimental density map
was of sufficient quality to allow for manual building of the entire RNA in
Coot (Emsley and Cowtan, 2004). The RNA was refined, initially against the
experimental phases and as a last step against the model phases using phe-
nix.refine. The refinement protocol included restrained coordinate refinement,
combined individual and TLS atomic displacement parameters for the entire
RNA, and occupancies for the ligand and heavy atoms. The ligand was placedAll rights reserved
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Structure of the THF Riboswitchat the last step of refinement with the assistance of 2Fo  Fc, Fo  Fc, and
experimental phasing maps. The crystallographic, phasing, and refinement
statistics are presented in Table 1. The 2Fo Fc map, and simulated annealing
maps omitting the ligands, are shown in Figure S2. The model, structure
factors, and experimental phases were deposited in the Protein Data Bank
(PDB) under ID codes 3SD1 and 3SD3 for wild-type and the U7C mutant,
respectively.
Isothermal Titration Calorimetry
The affinity of the RNA for a specific ligand of interest was performed using
previously described methods (Gilbert and Batey, 2009; Gilbert et al., 2007)
with a MicroCal ITC200 (GE Healthcare). RNA samples were dialyzed over-
night at 4C in buffer containing 10 mM HEPES (pH 8.0), 100 mM NaCl,
10 mM KCl, 1 mM DTT, and either 0.5 or 6 mMMgCl2. The ligand was brought
up from powder in matching dialysis buffer. Two hundred and seventy micro-
liters of 200–500 mM RNA was added to the sample cell, and the injector
contained 40 ml of 1–5 mM ligand. The amounts of the titrant and titrate
were such that the c value for each experiment was between 10 and 50 to
ensure accurate analysis of the resulting titration. Each titration was performed
at 25C. Raw data were integrated and fit using Origin ITC software (Microcal
Software).
Chemical Probing with N-Methylisatoic Acid
RNA was prepared as described previously (Stoddard et al., 2008, 2010).
Structure cassettes flanking the 50 and 30 ends of the RNA were added to
facilitate reverse transcription (Wilkinson et al., 2006). NMIA modification
was performed using the established protocols (Mortimer and Weeks, 2007;
Stoddard et al., 2008). RNA in 0.53 T.E. buffer was incubated for 2 min at
90C and then immediately placed on ice for 10 min. Eight microliters of stock
solution containing 900 nM RNA and 13 folding buffer (3.33 folding buffer:
333 mM K-HEPES [pH 8.0], 333 mM NaCl, and 20 mM MgCl2 for a final
concentration of 6 mM or 1.65 mM MgCl2 for a final concentration of
0.5mM) was added to thin-walled PCR tubes. Onemicroliter of ligand was dis-
solved in a solution of 1 mM DTT to make a final concentration of 500 mM. For
titrations, 1 ml of ligand was added of appropriate concentration. For ligand-
free samples, 1 ml of 1 mM DTT was added. To probe RNA, 1 ml of 130 mM
NMIA in DMSO was added to each aliquot. For control reactions, 1 ml of
DMSO was added. Samples were incubated for five half-lives of NMIA at
25C. Compensating amounts of MgCl2 were added back to samples contain-
ing 0.5 mM MgCl2 to insure condition matching for reverse transcription.
Samples were reverse transcribed by adding 3 ml of [32P]50 end-labeled DNA
oligomer to the solution. Reactions were incubated at 65C for 5 min, 35C for
10 min, and held at 54C. Samples were then supplemented with 7 ml of
enzyme mix (250 mM KCl, 167 mM Tris-HCl [pH 8.3], 16.7 mM DTT,
1.67 mM each dNTP, and 0.33 units of Superscript III reverse transcriptase
[Invitrogen]). Each reaction was incubated at 54C for 10 min. The reaction
was stopped by adding 1 ml of 4 M NaOH and incubated at 90C for 5 min.
Incubation continued for an additional 5 min after the addition of 29 ml of
acid stop mix. DNA was separated using a 12% denaturing polyacrylamide
gel, the gel was dried, and a Typhoon PhosphorImager (Molecular Dynamics)
was used to visualize results. Bands were aligned using SAFA (Das et al., 2005)
and quantified using SAFA or ImageJ (NIH). Data were fit to the Hill equation,
Q = a + (b  a)([ligand]n)/([ligand]n + KDn), where a and b are the lower and
upper baselines, respectively, and n is the Hill coefficient, using Igor Pro
(Wavemetrics).
Transcription Template Construction for In Vitro Transcription
Assays
DNA templates used for transcription assays were constructed by PCR ampli-
fication of overlapping oligonucleotides using standard methods. The THF
aptamer domain (nucleotides 5–84) was spliced into the expression platform
of the B. subtilis metE SAM-I riboswitch (Figure S2). This riboswitch has
been previously shown to regulate transcription by E. coli RNA polymerase
in an S-adenosylmethionine-dependent fashion (Artsimovitch and Henkin,
2009). The chimera was constructed in two pieces. The 50 piece consisted
of a T7A1 promoter followed by the native 50 metE sequence (including most
of P1), with the THF aptamer in place of the natural aptamer domain. The 30
portion was composed of the metE expression platform, which was PCRStructure 19, 1413–1amplified from B. subtilis genomic DNA. Recombinant PCR was used to
fuse these two portions. Mutant templates were obtained by altering the
desired nucleotides in the DNA oligonucleotides; the sequence of the Smu
folT/Bsu metE chimera is given in Figure S3.
In Vitro Transcription Assay
Single-turnover transcription reactions were performed essentially as
described in Dann et al. (2007). Briefly, 100 ng of DNA was incubated at
37C for 15 min in 25 ml of 23 transcription buffer (140 mM Tris-HCl [pH
8.0], 140 mM NaCl, 0.2 mM EDTA, 28 mM b-mercaptoethanol, and 70 mg/ml
BSA), 5 ml of 25 mM MgCl2, 1 mCi of [a-
32P]ATP, and 0.5 units of E. coli RNA
polymerase s70 holoenzyme obtained from Epicenter Biotechnologies to
a final volume of 35 ml. The reactions were initiated with the addition of 15 ml
of NTP mix (NTPs in equal molar ratios of 82.5 mM), 0.2 mg/ml heparin, and
the desired concentration of ligand. After incubation at 37C for 15 min, the
reactions were quenched with an equal volume of 8 M urea and a 2 min incu-
bation at 65C. The terminated and readthrough transcription products were
separated using a 6% denaturing polyacrylamide gel, dried, and exposed
overnight. Quantification of bands was performed with ImageQuant software
(Molecular Dynamics) and the data were fit to a Hill equation.
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